论文信息 - Vascularite cryoglobulinémique et traitement par rituximab Cryoglobulinemia-vasculitis and rituximab treatment - 字舞流文

Vascularite cryoglobulinémique et traitement par rituximab Cryoglobulinemia-vasculitis and rituximab treatment

M. Miyara | L. Musset | A. Brignoli

[1] Z. Amoura,et al. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. , 2009, Arthritis and rheumatism.

[2] J. Stoller,et al. Interstitial Pneumonitis and Alveolar Hemorrhage Complicating Use of Rituximab , 2007, Respiration.

[3] R. Fanin,et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. , 2003, Blood.

[4] M. Rashford,et al. Rituximab: Ongoing and future clinical development. , 2002, Seminars in oncology.

[5] D. L. Carrer. Les cryoglobulinémies : exploration biologique et signification clinique , 1995 .

[6] L. Musset,et al. Mixed cryoglobulinemia and hepatitis C virus. , 1994, The American journal of medicine.

[7] J. Clauvel,et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.